Ngenxa yezehlakalo zokubuyiselwa kabusha kwe-mitral valve kanye ne-mitral valve stenosis emhlabeni wonke, ngonyaka ka-2026, isifo senhliziyo se-mitral valve emakethe yokushintshwa kwe-transcatheter heart valve sizofinyelela ukukhula okukhulu kwama-23.1%.
I-PR Newswire-PR Newswire Selbyville, Delaware, USA, January 18, 2021-Ngokombiko wakamuva “Imakethe Yokushintshwa Kwevalve Yenhliziyo Ye-Transcatheter Ngomkhiqizo (I-Transcatheter Aortic Valve Replacement, Transcatheter Mitral) Ukulungiswa nokushintshwa kwevalve, ukushintshwa kwevalve ye-transcatheter pulmonary), izindlela (indlela ye-transfemoral, indlela ye-transapical), ukusetshenziswa (isifo senhliziyo se-aortic valve, isifo senhliziyo se-mitral valve, isifo senhliziyo ye-valve yamaphaphu), ukusetshenziswa kokuphela (izibhedlela, i-cath lab), umbono wesifunda, izitayela zamanani, isabelo semakethe sokuncintisana kanye nesibikezelo sika-2026 “ngo: Global market Insights, Inc, 2026, inani lemakethe lokuhlinzwa okushintshwa kwevalvu yenhliziyo ye-transcatheter lizoba ngaphezu kwezigidigidi eziyi-19.5. Idola.
Izinhlelo ezivumayo zokubuyisela eNyakatho Melika naseYurophu zizothuthukisa ukukhula kwemakethe. I-Medicare National Coverage Decision inqubomgomo ekhishwe yi-Medicare kanye ne-Centers for Medicaid Services (CMS) ukuvumela lawa mavalvu enhliziyo ukuthi ambozwe ukumbozwa okusekelwe ubufakazi e-United States. Ngo-2019, i-CMS yabuyekeza inqubomgomo yembuyiselo ye-Medicare yamavalvu e-transcatheter aortic. Uhlelo lokubuyisela (TAVR). Uma ukuhlinzwa kwenziwa ngokuhambisana nemiyalelo egunyazwe i-FDA, inqubomgomo entsha yokuvikela izoqhubeka nokumboza i-TAVR nge-Evidence Development (CED). Ngaphezu kwalokho, i-Belgium ne-France zihlinzeka ngembuyiselo yemikhiqizo ethile, kuyilapho kwamanye amazwe, ukubuyiselwa kwemali kwamadivayisi anjalo kunqunywa. EFrance, eJalimane naseSwitzerland kuphela okuyizimbuyiselo zezinhlobo ezahlukene zokuhlinzwa ezihlukile. EJalimane naseSwitzerland, izindleko zokuhlinzwa ngokusebenzisa indlela ye-apical ziphezulu. Le nqubomgomo yembuyiselo inyusa inani labantu abathola uhlelo lwe-TAVR.
Cela isampula yalo mbiko wocwaningo@ https://www.gminsights.com/request-sample/detail/3170
Intshisekelo ekhulayo yabakhiqizi emazweni asafufusa njengeMpumalanga Ephakathi ne-Afrika izothuthukisa ukwanda kwemakethe yokushintshwa kwamavalvu enhliziyo ye-transcatheter. Inani elikhulu labantu abahlukene eMpumalanga Ephakathi nase-Afrika bahlaselwa kakhulu yisifo senhliziyo nemithambo yegazi. Ngakho-ke, abakhiqizi bangaphandle bagxila ekuhlangabezaneni nesidingo kanye nokuhlinzekwa kwama-valve enhliziyo ye-transcatheter. Ukusabalala kwe-aortic valve stenosis eMpumalanga Ephakathi kukhulise ukwamukelwa kokuhlinzwa kwe-transcatheter heart valve replacement. Ngakho-ke, eMpumalanga Ephakathi nase-Afrika, abakhiqizi be-aortic valve babona amathuba amakhulu okukhula.
Ingxenye yemakethe ye-transcatheter pulmonary valve replacement yenani elingaphezu kwezigidi ezingama-537 zamaRandi ngo-2019. Ukushintshwa kwamavalvu e-Transcatheter pulmonary kusetshenziswa kakhulu ukwelapha ama-valve avuzayo noma aqinile e-pulmonary noma iziguli ezinokuxilonga okungaba khona kwama-valve wamaphaphu afakwe ngokuhlinzwa. Isibonelo, iziguli ezineziqu ze-arterial kanye neziguli ezine-pulmonary atresia noma ukuhlinzwa kukaRoss zidinga ukufaka esikhundleni se-transcatheter pulmonary valve. Ngaphezu kwalokho, i-transcatheter pulmonary valve inciphisa inani lokuhlinzwa kwenhliziyo okudingeka isiguli sikwenze ekuphileni kwaso. Lesi sici siphinde sibe nomthelela ekudingeni ama-transcatheter pulmonary valves.
Indlela ye-transapical emakethe yokushintshwa kwevalvu yenhliziyo ye-transcatheter yeqe i-US$1.16 billion ngo-2019. Indlela ye-transapical iyindlela ekhethwayo ngoba ukusondela komsebenzisi ku-valve kungawela kalula i-valve yemvelo ngohlelo lokulethwa. Le ndlela ingase futhi ivimbele uhlelo lokulethwa ukuthi lungadluli eduze kwe-aortic arch, ngaleyo ndlela kuncishiswe ingozi yokushaywa unhlangothi ekufakweni kwe-transcatheter aortic valve. Ngaphezu kwalokho, indlela ye-transapical iyindlela yokuzikhethela kubahlinzeki abaningi bezempilo ngoba inikeza izinga eliphansi kakhulu lezinkinga ezihlobene nendlela. Lezi zinto zingase ziqhube isidingo samavalvu enhliziyo e-transcatheter.
Ngenxa yesigameko somhlaba wonke sokubuyiselwa kabusha kwe-mitral kanye ne-mitral valve stenosis, imakethe ye-transcatheter heart valve replacement for mitral valve heart disease izokhombisa izinga lokukhula elingaphezu kuka-23.1% ngo-2026. Ngokwezindatshana ezishicilelwe, abantu abangaphezu kwezigidi ezine I-United States ihlushwa i-mitral regurgitation, futhi izehlakalo zonyaka zingaba ngu-50,000. Kutuswa ukuthi iziguli ezinalesi simo zifakwe esikhundleni se-transcatheter mitral valve. Ngakho-ke, isidingo sama-transcatheter heart valves sikhula ngokushesha. Imishini yokushintsha i-transcatheter mitral valve ibhekene nokuhlolwa okungenzeka, okuzoqhubeka nokugqugquzela inani leziguli ezishintshwayo.
Kulinganiselwa ukuthi ngo-2026, ingxenye yesibhedlela emakethe yokushintshwa kwe-valve yenhliziyo ye-transcatheter izokhula ku-CAGR ye-14.1%. Izibhedlela zizothola imbuyiselo evumayo, ephoqelela iziguli phakathi kwezinye izikhungo zezokwelapha ukuba zikhethe izibhedlela zokuhlinzwa esikhundleni se-valve yenhliziyo ye-transcatheter ngenxa yezindleko eziphezulu zalokhu kuhlinzwa. Ngaphezu kwalokho, ukwanda kwesinyathelo sikahulumeni sokulawula izifo zamavalvu kungesinye isici ekwandiseni umkhakha wezibhedlela.
IBrazil ibusa imakethe yokushintsha i-valve yenhliziyo ye-transcatheter eLatin America. Iqhutshwa ukwanda kwabantu asebekhulile abahlushwa isifo se-aortic valve, iBrazil yabalelwa ku-$47 million ngo-2019. Eminyakeni embalwa edlule, inani leziguli ezine-non-rheumatic calcified aortic disease eBrazil liye landa kakhulu. Ngakho-ke, eminyakeni yamuva nje, ukwamukelwa kwasekhaya kwe-transcatheter heart valve replacement technology kuye kwanda, okuye kwaholela ekwandeni kwesidingo nokunikezwa kwama-valve enhliziyo ye-transcatheter. Ukwanda okusheshayo kwenani lezibhedlela ezweni kanye nokuba khona okuqinile kwabadlali bemboni abaziwayo abatshala imali ekuthuthukiseni ama-valve enhliziyo amasha e-transcatheter kuye kwakhuthaza nakakhulu isidingo semakethe.
Ezinye zezinkampani ezinkulu ezisebenza emakethe yokushintsha i-valve yenhliziyo ye-transcatheter zifaka i-4C Medical Technologies, i-Abbott, i-Boston Scientific, i-Edward Lifesciences, i-HighLife Medical, i-JC Medical, i-LivaNova, i-Medtronic plc ne-Neovasc. Abahlanganyeli bemboni bebelokhu begxile ekukhishweni kwemikhiqizo emisha ukuze bandise indawo yabo kanye nesisekelo samakhasimende.
I-Global Market Insights, Inc., enekomkhulu e-Delaware, iwucwaningo lwemakethe yomhlaba wonke kanye nomhlinzeki wesevisi wokubonisana, ehlinzeka ngemibiko yocwaningo edidiyelwe neyenziwe ngokwezifiso kanye nezinsizakalo zokubonisana nokukhula. Imibiko yethu yobuhlakani bebhizinisi kanye nocwaningo lwemboni ihlinzeka amakhasimende ngemininingwane enemininingwane kanye nedatha yemakethe esebenzayo, eklanywe ngokukhethekile futhi ikhonjiswe ukusiza izinqumo zamasu. Le mibiko enemininingwane iklanywe ngezindlela zokucwaninga zobunikazi futhi ingasetshenziswa ezimbonini ezibalulekile ezifana nekhemistri, izinto ezithuthukisiwe, ubuchwepheshe, amandla avuselelekayo kanye ne-biotechnology.
U-Arun Hegde (Arun Hegde) Inkampani YaseMelika Yokuthengisa I-Global Market Insights Inkampani Ucingo: 1-302-846-7766 Inombolo Yamahhala: 1-888-689-0688 I-imeyili: [I-imeyili ivikelwe]
I-transcatheter-heart-valve.png Ngo-2026, izinga lokukhula kwemakethe yokushintsha i-valve yenhliziyo ye-transcatheter kulindeleke ukuthi libe ngu-17.6%: GMI: Abadlali abakhulu bemakethe ekushintshweni kwe-transcatheter heart valve bahlanganisa i-4C Medical Technologies, Abbott, Boston Scientific, Edwards Life. Isayensi, i-HighLife Medical, i-JC Medical, i-LivaNova, i-Medtronic plc.
Isikhathi sokuthumela: Jan-19-2021
